Compatibility of intravenous metronidazole with some all-in-one parenteral nutrition regimens
- PMID: 33139150
- DOI: 10.1016/j.nut.2020.111020
Compatibility of intravenous metronidazole with some all-in-one parenteral nutrition regimens
Abstract
Objectives: Supplementation of parenteral nutrition (PN) admixtures with other parenteral drugs may be desired especially in the case of polypharmacy and limited vascular access. Metronidazole (MTZ) is administered in surgical and critically ill patients often requiring concomitant nutritional therapy in the form of parenteral nutrition. The aim of the study was to evaluate the possibility of the concomitant administration of MTZ with PN admixtures from one container.
Methods: MTZ (1500 mg) was combined with six different PN admixtures and stored for 7 days before the simulation of administration. The mean droplet size (MDS) of the lipid emulsion, zeta potential, color, and pH of the tested samples were determined every 24 h. The content of MTZ was determined by the high-performance liquid chromatography method within the same time frames.
Results: PN admixtures supplemented with MTZ were characterized by a pH range from 6.19 to 6.38 and zeta potential range from -21.6 mV to -8.8 mV. For all samples the pharmacopeial criteria for intravenously administered emulsions were met: The visual inspection showed no sign of emulsion destabilization or precipitation, and the MDS was <500 nm. The MTZ content remained >90% of the initial value throughout the whole study period.
Conclusions: Results showed the physicochemical compatibility and stability of PN admixtures supplemented with MTZ at the dose of 1500 mg. Such formulations can be stored at a temperature of 5°C for up to 7 d before administration to the patient.
Keywords: mean droplet size; parenteral nutrition; stability.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Physicochemical Stability and Sterility of Standard Parenteral Nutrition Solutions and Simulated Y-Site Admixtures for Neonates.Nutr Clin Pract. 2018 Oct;33(5):694-700. doi: 10.1002/ncp.10013. Epub 2018 Feb 21. Nutr Clin Pract. 2018. PMID: 29464781
-
In vitro compatibility studies of vancomycin with ready-to-use parenteral nutrition admixtures for safer clinical practice.Clin Nutr. 2020 Aug;39(8):2539-2546. doi: 10.1016/j.clnu.2019.11.014. Epub 2019 Nov 15. Clin Nutr. 2020. PMID: 31784302
-
Stability Study and Clinical Evaluation of Lipid Injectable Emulsion in Parenteral Nutrition Admixtures Used for Preterm Neonates.Nutr Clin Pract. 2021 Jun;36(3):696-703. doi: 10.1002/ncp.10556. Epub 2020 Jul 16. Nutr Clin Pract. 2021. PMID: 32671868
-
Y-Site Compatibility Studies of Parenteral Nutrition and Other Intravenous Medications in Neonatal and Pediatric Patients: A Review of the Literature Evidence.Pharmaceutics. 2024 Feb 12;16(2):264. doi: 10.3390/pharmaceutics16020264. Pharmaceutics. 2024. PMID: 38399318 Free PMC article. Review.
-
Use of Intravenous Lipid Emulsions With Parenteral Nutrition: Practical Handling Aspects.JPEN J Parenter Enteral Nutr. 2020 Feb;44 Suppl 1:S74-S81. doi: 10.1002/jpen.1737. JPEN J Parenter Enteral Nutr. 2020. PMID: 32049398 Review.
Cited by
-
Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery.Curr Drug Targets. 2024;25(5):306-329. doi: 10.2174/0113894501284598240226102943. Curr Drug Targets. 2024. PMID: 38454772 Review.
-
Physicochemical Compatibility of Ceftolozane-Tazobactam with Parenteral Nutrition.Pharmaceuticals (Basel). 2024 Jul 5;17(7):896. doi: 10.3390/ph17070896. Pharmaceuticals (Basel). 2024. PMID: 39065746 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous